Our Sectors.

Read our latest articles and posts on medical and our company.

Meet Our Team
nn 00-Icons/Pharman n n n n n n n n n n
nn 00-Icons/Biotechn n n n n n n n
nn 00-Icons/Medtechn n n n n n n n n n n n n n n n n n n n n n

Medtech & Healthtec

Healthcare challenges.

The medical technology industry is expected to continue facing significant growth challenges over the next few years as increased competition, an increasingly stringent regulatory and policy environment, and continued concerns about rising healthcare costs and buyer consolidation are all expected to significantly impact the sector.

00-Icons/Medtech-icon-1

Increased competition

00-Icons/Medtech-icon-2

Increasingly stringent regulatory and policy environment

00-Icons/Medtech-icon-3

Continued concerns about rising healthcare costs

These challenges will be most exacerbated in mature segments of the industry, such as hospital equipment, orthopedics and cardiovascular where pricing pressures are expected to increase, most particularly in traditional markets such as the United States and Europe.

To address their growth challenges, Med Tech companies will have to increasingly turn to M&A to complement internal efforts.

KYBORA’s internal research.

Companies in the sector must become more sophisticated in exploring M&A opportunities by focusing on disciplined value-creation deals in mature markets, geographic expansion deals into emerging markets with faster growth, and business model transformation deals in traditional segments (allowing companies to offer integrated solutions vs. single products to customers).

Sector insights.

Companies in the sector must become more sophisticated in exploring M&A opportunities by focusing on disciplined value-creation deals in mature markets, geographic expansion deals into emerging markets with faster growth, and business model transformation deals in traditional segments (allowing companies to offer integrated solutions vs. single products to customers).

Contact us.

KYBORA can help you achieve these objectives by leveraging our network of MedTech professionals around the globe.  If you have any needs in MedTech M&A, please reach out to us.

I was born and raised in Rwanda. In Kinyarwanda, the word “kuyobora” means “Guide.”
I wanted to use this word because guiding our clients to success is at the core of KYBORA’s principles and values.

Alan Vanderborght

CEO Kybora

Clients & Counterparties.

Meet our team.

Our team is passionate about helping life sciences companies succeed.

CEO & Chairman of the BoD
EVP & Managing Director - Board Member KYBORA GmbH
Felix Lara
Board Member KYBORA GmbH

TYPE & ENTER: